As of 2024-12-13, the Fair Value of Biohaven Pharmaceutical Holding Company Ltd (BHVN) is -39.77 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 40.16 USD, the upside of Biohaven Pharmaceutical Holding Company Ltd is -199.03%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | - | 5Y Avg | |
| Net income | -213.80 | -570.28 | -408.17 | - | -397.42 | |
| YoY growth | -80.16% | -166.74% | 28.43% | - | -72.82% | |
| Market Cap (mil) | 4,060.98 |
| P/E | |
| Forward P/E |
| EPS | -7.95 |
| Avg earnings growth rate | -72.82% |
| TTM earnings | -804.34 |